Starpharma Holdings Limited (OTCMKTS:SPHRY) Short Interest Update

Starpharma Holdings Limited (OTCMKTS:SPHRY) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 2,600 shares, a decline of 42.2% from the October 31st total of 4,500 shares. Based on an average daily volume of 12,000 shares, the short-interest ratio is presently 0.2 days.

Starpharma Price Performance

Shares of SPHRY remained flat at $0.67 during trading hours on Friday. 50 shares of the stock traded hands, compared to its average volume of 5,499. Starpharma has a fifty-two week low of $0.52 and a fifty-two week high of $1.33. The company’s 50 day moving average price is $0.68 and its two-hundred day moving average price is $0.65. The company has a debt-to-equity ratio of 0.07, a quick ratio of 4.58 and a current ratio of 4.94.

About Starpharma

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.